174 related articles for article (PubMed ID: 21306815)
21. Five-year survival after second-line cisplatin-based intraperitoneal chemotherapy for advanced ovarian cancer.
Recio FO; Piver MS; Hempling RE; Driscoll DL
Gynecol Oncol; 1998 Mar; 68(3):267-73. PubMed ID: 9570979
[TBL] [Abstract][Full Text] [Related]
22. Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study.
Pomel C; Ferron G; Lorimier G; Rey A; Lhomme C; Classe JM; Bereder JM; Quenet F; Meeus P; Marchal F; Morice P; Elias D
Eur J Surg Oncol; 2010 Jun; 36(6):589-93. PubMed ID: 20466507
[TBL] [Abstract][Full Text] [Related]
23. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Rasch CR; Schornagel JH; Dreschler WA; Balm AJ
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1320-5. PubMed ID: 17418969
[TBL] [Abstract][Full Text] [Related]
24. Secondary surgical cytoreduction for advanced ovarian carcinoma.
Rose PG; Nerenstone S; Brady MF; Clarke-Pearson D; Olt G; Rubin SC; Moore DH; Small JM;
N Engl J Med; 2004 Dec; 351(24):2489-97. PubMed ID: 15590951
[TBL] [Abstract][Full Text] [Related]
25. A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: a Gynecologic Oncology Group study.
Feun LG; Blessing JA; Major FJ; DiSaia PJ; Alvarez RD; Berek JS
Gynecol Oncol; 1998 Dec; 71(3):410-5. PubMed ID: 9887240
[TBL] [Abstract][Full Text] [Related]
26. Risk factors of acute renal failure in critically ill children: A prospective descriptive epidemiological study.
Bailey D; Phan V; Litalien C; Ducruet T; Mérouani A; Lacroix J; Gauvin F
Pediatr Crit Care Med; 2007 Jan; 8(1):29-35. PubMed ID: 17251879
[TBL] [Abstract][Full Text] [Related]
27. Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma.
Helm CW; Randall-Whitis L; Martin RS; Metzinger DS; Gordinier ME; Parker LP; Edwards RP
Gynecol Oncol; 2007 Apr; 105(1):90-6. PubMed ID: 17173957
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of continuous veno-venous hemofiltration for the treatment of cardiogenic shock in conjunction with acute renal failure after cardiac surgery.
Vidal S; Richebé P; Barandon L; Calderon J; Tafer N; Pouquet O; Fournet N; Janvier G
Eur J Cardiothorac Surg; 2009 Sep; 36(3):572-9. PubMed ID: 19482487
[TBL] [Abstract][Full Text] [Related]
29. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
Levesque MA; Katsaros D; Massobrio M; Genta F; Yu H; Richiardi G; Fracchioli S; Durando A; Arisio R; Diamandis EP
Clin Cancer Res; 2000 Aug; 6(8):3260-70. PubMed ID: 10955812
[TBL] [Abstract][Full Text] [Related]
30. RIFLE-based data collection/management system applied to a prospective cohort multicenter Italian study on the epidemiology of acute kidney injury in the intensive care unit.
Garzotto F; Piccinni P; Cruz D; Gramaticopolo S; Dal Santo M; Aneloni G; Kim JC; Rocco M; Alessandri E; Giunta F; Michetti V; Iannuzzi M; Belluomo Anello C; Brienza N; Carlini M; Pelaia P; Gabbanelli V; Ronco C;
Blood Purif; 2011; 31(1-3):159-71. PubMed ID: 21228585
[TBL] [Abstract][Full Text] [Related]
31. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.
Skarlos DV; Aravantinos G; Kosmidis P; Athanassiadis A; Stathopoulos GP; Pavlidis N; Bafaloukos D; Karphathios S; Papakostas P; Bamia C; Fountzilas G
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224
[TBL] [Abstract][Full Text] [Related]
32. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
Serkies K; Jassem J
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of RIFLE classification on prognosis of critically ill patients with acute kidney injury treated with continuous renal replacement therapy.
Li WX; Chen HD; Wang XW; Zhao S; Chen XK; Zheng Y; Song Y
Chin Med J (Engl); 2009 May; 122(9):1020-5. PubMed ID: 19493435
[TBL] [Abstract][Full Text] [Related]
34. Endotoxin and cisplatin synergistically induce renal dysfunction and cytokine production in mice.
Ramesh G; Zhang B; Uematsu S; Akira S; Reeves WB
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F325-32. PubMed ID: 17494092
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin nephrotoxicity: a multivariate analysis of potential predisposing factors.
Lagrange JL; Médecin B; Etienne MC; Pivot X; Cassuto-Viguier E; Renée N; Thyss A; Ferrero JM; Otto J; François E; Milano G
Pharmacotherapy; 1997; 17(6):1246-53. PubMed ID: 9399607
[TBL] [Abstract][Full Text] [Related]
36. Renal function after port access and median sternotomy mitral valve surgery.
Antonic M; Gersak B
Heart Surg Forum; 2007; 10(5):E401-7. PubMed ID: 17855207
[TBL] [Abstract][Full Text] [Related]
37. The risk factors of severe acute kidney injury induced by cisplatin.
Mizuno T; Ishikawa K; Sato W; Koike T; Kushida M; Miyagawa Y; Yamada K; Hirata S; Imai E; Noda Y
Oncology; 2013; 85(6):364-9. PubMed ID: 24335484
[TBL] [Abstract][Full Text] [Related]
38. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
[TBL] [Abstract][Full Text] [Related]
39. Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma.
Jones E; Alvarez Secord A; Prosnitz LR; Samulski TV; Oleson JR; Berchuck A; Clarke-Pearson D; Soper J; Dewhirst MW; Vujaskovic Z
Int J Hyperthermia; 2006 Mar; 22(2):161-72. PubMed ID: 16754599
[TBL] [Abstract][Full Text] [Related]
40. RIFLE criteria for acute kidney injury in valvular surgery.
De Santo LS; Romano G; Galdieri N; Buonocore M; Bancone C; De Simone V; Della Corte A; Nappi G
J Heart Valve Dis; 2010 Jan; 19(1):139-47; discussion 148. PubMed ID: 20329500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
